Atovaquone-Proguanil
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-23-R-0013
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents5
The Defense Logistics Agency (DLA) Troop Support, a federal office, issued a solicitation under procurement identifier SPE2D2-23-R-0013 for a national contract for Atovaquone-Proguanil. This procurement seeks to establish a reliable supply of Atovaquone-Proguanil, a pharmaceutical preparation commonly used for malaria prophylaxis and treatment, to support the needs of military personnel and other authorized users.
The scope of this solicitation encompasses the manufacturing and delivery of Atovaquone-Proguanil in accordance with the standards outlined under NAICS Code 325412, which pertains to Pharmaceutical Preparation Manufacturing. The associated Product Service Code is 6505, indicating a focus on drugs and biologicals. Contractors are expected to provide products that meet all applicable regulatory and quality requirements for pharmaceutical preparations, ensuring safety, efficacy, and consistency throughout the contract lifecycle.
DLA Troop Support, as the contracting entity, is responsible for managing this procurement. Interested parties should note that the solicitation was posted on November 13, 2023, with responses due by November 20, 2023. Although the notice is currently inactive, the opportunity was originally published on SAM.gov, where additional attachments related to the solicitation are available for review.
Key contacts for this procurement include Joshua Tankel ([email protected], 215-737-2745) and Jason Wray ([email protected], 215-737-0614), who can provide further information regarding the solicitation requirements and submission procedures.
This opportunity is classified as a solicitation, indicating that DLA Troop Support is seeking competitive proposals from qualified manufacturers. There is no information provided regarding set-aside requirements or special considerations such as small business preferences or socioeconomic program participation.
Contractors evaluating this opportunity should ensure their capabilities align with the manufacturing, quality assurance, and delivery requirements for Atovaquone-Proguanil as specified under the relevant NAICS and PSC codes. The contract is intended to secure a dependable source of this critical pharmaceutical product for national defense and related applications, with expectations for compliance, reliability, and responsiveness throughout the duration of the agreement.
For further details and access to solicitation documents, contractors are encouraged to visit the official notice on SAM.gov at https://sam.gov/opp/2ba92aaa528544a889865a782f7c8da5/view.